Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Yngvar NilssenOdd Terje BrustugunMorten Tandberg EriksenErik Skaaheim HaugBjørn NaumeBjørn MøllerPublished in: BMC cancer (2020)
The national target of 70% was met within 1 year of CPP implementation in Norway. Although all patients should have equal access to CPPs, a prostate cancer diagnosis, older age, high level of comorbidity or low income were significantly associated with an increased odds of not being included in a CPP.